Literature DB >> 6191986

Interferon in acute viral infections.

S Levin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6191986     DOI： 10.1007/bf00661894

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  17 in total

1.  Interferon response of human leukocytes during intrauterine and postnatal life.

Authors:  K Cantell; H Strander; L Saxén; B Meyer
Journal:  J Immunol       Date:  1968-06       Impact factor: 5.422

Review 2.  Interferon: therapeutic fact or fiction for the '80s?

Authors:  G M Scott; D A Tyrrell
Journal:  Br Med J       Date:  1980-06-28

3.  From the National Institute of Allergy and Infectious Diseases. Update on clinical trials with exogenous interferon.

Authors:  J K Dunnick; G J Galasso
Journal:  J Infect Dis       Date:  1980-08       Impact factor: 5.226

4.  Interferon in chronic hepatitis B infection.

Authors:  T C Merigan; W S Robinson; P B Gregory
Journal:  Lancet       Date:  1980-02-23       Impact factor: 79.321

5.  Interferon system in acute viral hepatitis.

Authors:  S Levin; T Hahn
Journal:  Lancet       Date:  1982-03-13       Impact factor: 79.321

6.  Toxicity of interferon.

Authors:  G M Scott; D S Secher; D Flowers; J Bate; K Cantell; D A Tyrrell
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-25

7.  Evaluation of the human interferon system in viral disease.

Authors:  S Levin; T Hahn
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

8.  Intrathecal interferon reduces exacerbations of multiple sclerosis.

Authors:  L Jacobs; J O'Malley; A Freeman; R Ekes
Journal:  Science       Date:  1981-11-27       Impact factor: 47.728

9.  Treatment of life-threatening viral infections with interferon alpha: pharmacokinetic studies in a clinical trial.

Authors:  S Levin; T Hahn; H Rosenberg; T Bino
Journal:  Isr J Med Sci       Date:  1982-04

10.  Production of immune and viral interferon by lymphocytes of newborn infants.

Authors:  T Hahn; S Levin; Z T Handzel
Journal:  Isr J Med Sci       Date:  1980-01
View more
  7 in total

1.  Antiherpetic effects of a human alpha interferon analog, IFN-alpha Con1, in hamsters.

Authors:  E N Fish; K Banerjee; H L Levine; N Stebbing
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

2.  Acyclovir therapy for chickenpox in children with hematological malignancies.

Authors:  J Bogusławska-Jaworska; E Kościelniak; B Rodziewicz
Journal:  Eur J Pediatr       Date:  1984-06       Impact factor: 3.183

3.  Pilot study of recombinant interferon alpha-2a for treatment of infants with bronchiolitis induced by respiratory syncytial virus.

Authors:  J Portnoy; R Hicks; F Pacheco; L Olson
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

4.  Enhanced efficacy of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine in combination with beta-interferon against herpes simplex virus type 2 in mice.

Authors:  E B Fraser-Smith; D A Eppstein; Y V Marsh; T R Matthews
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

5.  Interferon system in acute transient synovitis.

Authors:  E Leibowitz; S Levin; J Torten; R Meyer
Journal:  Arch Dis Child       Date:  1985-10       Impact factor: 3.791

6.  Enhanced therapeutic efficacy of poly(ICLC) and ribavirin combinations against Rift Valley fever virus infection in mice.

Authors:  M Kende; H W Lupton; W L Rill; H B Levy; P G Canonico
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

7.  Synergistic activity of combinations of recombinant human alpha interferon and acyclovir, administered concomitantly and in sequence, against a lethal herpes simplex virus type 1 infection in mice.

Authors:  E V Connell; R L Cerruti; P W Trown
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.